Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Rheumatoid Arthritis

  Free Subscription


5 Ann Rheum Dis
1 Arthritis Res Ther
3 Clin Exp Rheumatol
6 Clin Rheumatol
1 J Clin Invest
3 PLoS One
4 Rheumatol Int
1 Z Rheumatol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Rheum Dis

  1. FELSON D, Lacaille D, LaValley MP, Aletaha D, et al
    Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment.
    Ann Rheum Dis. 2021 Nov 16. pii: annrheumdis-2021-221653.

  2. MEEHAN GR, Thomas R, Al Khabouri S, Wehr P, et al
    Preclinical models of arthritis for studying immunotherapy and immune tolerance.
    Ann Rheum Dis. 2021;80:1268-1277.
    PubMed         Abstract available

  3. NIKIPHOROU E, Santos EJF, Marques A, Bohm P, et al
    2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.
    Ann Rheum Dis. 2021;80:1278-1285.
    PubMed         Abstract available

  4. TANAKA Y, Oba K, Takeuchi T
    Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al.
    Ann Rheum Dis. 2021;80:e173.

  5. BERKHOUT LC, l'Ami MJ, Wolbink GJ, Rispens T, et al
    Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al.
    Ann Rheum Dis. 2021;80:e172.

    Arthritis Res Ther

  6. DOUMEN M, De Cock D, Pazmino S, Bertrand D, et al
    Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis.
    Arthritis Res Ther. 2021;23:285.

    Clin Exp Rheumatol

  7. ALDRIDGE J, Lundell AC, Andersson K, Mark L, et al
    Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17505.
    PubMed         Abstract available

  8. SUGAWARA M, Fujieda Y, Noguchi A, Tanimura S, et al
    Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17548.
    PubMed         Abstract available

  9. LAYEGH Z, Hooijberg F, Bastida C, Huitema ADR, et al
    Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17173.

    Clin Rheumatol

  10. RAI B, Pillinger MH, Panush RS
    Coincident Kikuchi-Fujimoto's disease and adult-onset Still's disease: report of a patient from an uncommonly affected population and case-directed systematic review.
    Clin Rheumatol. 2021;40:4791-4805.
    PubMed         Abstract available

  11. VIEGAS-COSTA LC, Friesen R, Flores-Mir C, McGaw T, et al
    Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.
    Clin Rheumatol. 2021;40:4817-4828.
    PubMed         Abstract available

  12. LEBLEBICI G, Ovacik U, Gungor F, Davids JR, et al
    Validity and reliability of "Shriners Hospital for Children Upper Extremity Evaluation" in children with rheumatic diseases.
    Clin Rheumatol. 2021;40:5033-5040.
    PubMed         Abstract available

  13. MIRTAHERI E, Khabbazi A, Nazemiyeh H, Ebrahimi AA, et al
    Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial.
    Clin Rheumatol. 2021 Nov 11. pii: 10.1007/s10067-021-05981.
    PubMed         Abstract available

  14. CHEN Y, Liao R, Yao Y, Wang Q, et al
    Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network.
    Clin Rheumatol. 2021 Nov 12. pii: 10.1007/s10067-021-05960.
    PubMed         Abstract available

  15. NAGAFUCHI H, Goto Y, Kiyokawa T, Ooka S, et al
    Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive.
    Clin Rheumatol. 2021 Nov 15. pii: 10.1007/s10067-021-05985.
    PubMed         Abstract available

    J Clin Invest

  16. LEVESCOT A, Chang MH, Schnell J, Nelson-Maney N, et al
    IL-1beta-driven osteoclastogenic Tregs accelerate bone erosion in arthritis.
    J Clin Invest. 2021;131.
    PubMed         Abstract available

    PLoS One

  17. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
    Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    PLoS One. 2021;16:e0259389.
    PubMed         Abstract available

  18. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
    Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
    PLoS One. 2021;16:e0260254.
    PubMed         Abstract available

  19. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
    Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
    PLoS One. 2021;16:e0256135.
    PubMed         Abstract available

    Rheumatol Int

  20. MANOJ M, Sahoo RR, Singh A, Hazarika K, et al
    Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Rheumatol Int. 2021;41:929-937.
    PubMed         Abstract available

  21. HEGEMAN MC, Schoemaker-Delsing JA, Luttikholt JTM, Vonkeman HE, et al
    Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.
    Rheumatol Int. 2021;41:973-979.
    PubMed         Abstract available

  22. ROMERA BAURES M, Seoane-Mato D, Alegre-Sancho JJ, Leon L, et al
    Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
    Rheumatol Int. 2021 Nov 16. pii: 10.1007/s00296-021-05043.
    PubMed         Abstract available

  23. MASLINSKA M, Manczak M, Kwiatkowska B, Ramsperger V, et al
    IgA immunoglobulin isotype of rheumatoid factor in primary Sjogren's syndrome.
    Rheumatol Int. 2021;41:643-649.
    PubMed         Abstract available

    Z Rheumatol

  24. SUNG YK, Lee YH
    The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2021 Nov 10. pii: 10.1007/s00393-021-01126.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.